Points for discussion: 

• In house manufacturing or using a CDMO is one of the key questions during a cell therapy development process
• This panel will discuss the key considerations to address this question and also elaborate on what a good fit in terms of CDMO might look like
• What are the hurdles and how to overcome them to successfully use a partnership with a CDMO to de-risk your development process

Agenda

12:30pm Panel

1:10pm Q&A

Moderator:

Robert Hughes, Vice President & General Manager, Miltenyi Bioindustry

Speakers:

Anthony Davies, Founder & CEO, Dark Horse Consulting

Azadeh Golipour, Chief Technical Officer, AVROBIO

Ian Gaudet, Senior Director Site Head San Jose, Miltenyi Bioindustry